In the present study, we showed that catalytic mTOR inhibitors more effectively inhibited the viability of colon cancer cells than the allosteric inhibitor rapamycin, as rapamycin led to only a partial inhibition of the mTORC1 complex through a weak inhibition of 4EBP phosphorylation. The gene discussed is MTOR; the disease is malignant colon neoplasm.